Friday 23rd April 2027

13:30  Welcome and introduction (S. Aebi, Luzern)

13:40  How to read a “next generation” sequencing report (M. Matter, Basel)

14:10  Which surrogate endpoints are useful in clinical trials of breast cancer? (A. Wolfer, Genève)

14:40  Common sense Breast Cancer Oncology (D. Trapani, Milano)

15:15  Case presentations

15:35  Coffee break

16:05  Multigene expression signatures: are they all the same? (A. Oseledchyk, Basel)

16:40  Is early detection of relapse or progression essential? (J. Sandoval, Genève)

17:15  Who should get immunotherapy now – and in the near future? (R. Bill, Bern)

17:50  Case presentations

18:15   Adjourn

Saturday 24th April 2027

08:00  ADCs in breast cancer: An overview and future outlook (K. Zaman, Lausanne)

08:30  Current endocrine-based therapy (A.Stravodimou, Lausanne)

09:00  Breast cancer in pregnancy, pregnancy after breast cancer (F. Schwab, Basel)

09:30  Optimizing the treatment of the axilla (M. Gasparri, Lugano)

10:00  Coffee break

10:30  Oncological rehabilitation after breast cancer (K. Zeidler, LUKS-Gruppe)

11:00  Key takeaways from the St.Gallen/Vienna Consensus Conference 2027 (M. Vetter, Liestal)

11:30  Discussion and wrap-up

12:00   End